Research and development are the prime essences of the entire pharmaceutical industry even at the international level. It is impossible to carry on a drug business or improve the healthcare sector without the help of extensive research. The absence of a proper, well-versed, and dedicated R and D department would mean a deteriorating status of health, an increase in diseases, lesser means of curing, and everything upside down.
But, things seem to take a backseat when it comes to the research works pediatric pharma. Even some studies reveal that only 1/3rd or 1/4th of the total pharma products available in the market are from the pediatric category. This lesser percentage implies a shortage of research effort in this sphere which is a subject of great concern.
Find below more persuasive points to know about the role of R & D in pediatric pharma parent companies and the Pediatric Products Franchise thereof.
-
Kids and adults respond differently
Everybody needs to understand that newborn babies and growing toddlers do not respond to medicines as same as adults. The reasons behind this variation are distinct drug metabolism and different cellular reactions to medicines. Giving adult medicines to youngsters can result in side effects and other health problems. Thus, there is a dire need to conduct extensive researches to manufacture pharma products specifically for kids. So that can comply with their responsiveness most appropriately.
-
Lack of subject response
Another major problem with developing pediatric pharma products is the lesser opportunities for subject testing. It is known that all pharma drugs are launched into the market for treatment and consumption only after full-proof clinical trials. And, for clinical trials, there is a dire need for having subjects as same as those consumers or patients for whom the drug is under development. In the case of pediatric drugs, it becomes difficult to reach the last stage of clinical trials due to a lack of suitable subjects.
Thereby, one needs to come up with better and more promising alternatives to make the research and development of pharmaceutical drugs for children. Contact companies like Rehan Care ensuring their active indulgence through a qualified R and D department, especially for the pediatric segment.
-
Developing safer and newer solutions
Lack of proper trials and pediatric drugs compel the doctors to prescribe adult pharma products even to children. Due to the different responsive abilities of kids and adults, there is a risk of administering adult medicines to tiny toddlers. So, it is highly imperative to conduct research and develop better formulations for kids specifically. It will help in offering safer dosages and better medical treatments to the pediatric sector.
Conclusion
From the above points, it is amply clear that research and development are utterly crucial for pediatric pcd pharma franchise company. It is only through continuous and extensive R and D that we can achieve new heights of healthcare assurance for kids. Therefore, if you aspire to be a productive, holistic, and wholesome PCD Pharma Franchise Company for Pediatric, you should select a parent company focusing on extensive research and development.
